Back to News and Inforamtion ADA 2000 Scientific Sessions
The American Diabetes Association 2000 Scientific Sessions, to held in San Antonio in June 2000, will offer an opportunity to learn about the latest in diabetes research, meet with researchers and clinicians, and meet with industry representatives. Below is our report.

New Products

Companies that make products for people with diabetes often introduce new and updated products at the ADA conference. Here are a few selected highlights:

  1. Disetronic introduced two new pumps and a new infusion set:

    D-Tron   Disetronic's new top-of-the-line pump is the D-Tron. The D-Tron includes two basal profiles (for weekdays and weekends, for example), extended bolus delivery, and multi-wave bolus (increase basal while delivering a bolus). The D-Tron will accept pre-filled cartridges (pending FDA approval) and comes with a pen backup, rather than a second pump like the H-Tron series. See the Disetronic web site for more information.

    Dahedi   The Dahedi pump takes a minimalist approach to pumping, reducing features to those used most often and size to about half that of other insulin pumps. The Dahedi offers a single basal profile with hourly rates (like the H-Tron), bolus increments of 0.5 units, and is waterproof. Most important is it's size: the Dahedi is extremely small and is therefore more easily concealed than other pumps. For people interested in pump thereapy but concerned about the size of pumps, the Dahedi offers an excellent alternative. See the Dahedi web site for more information.

    Dahedi   The new Ultrafex infusion set looks like a cross between a Disetronic Tender and a MiniMed Sof-Set. The infusion set inserts straight into the skin like the Sof-Set, but has an at-the-site disconnect like the Tender, effectively offering the best features of both infusion sets. With three different canula depths, the Ultraflex meets the needs of all pumpers. The Ultraflex uses a standard luer lock and can be used with all insulin pumps.

  2. Animas showed their pump, newly approved by the FDA:

    Dahedi   Animas showed their new pump, which received FDA approval earlier in 2000. Animas worked with pump patients from across the country to help design a pump that included the best features from other pumps and new features that patients asked for. The Animas pump delivers basal insulin every three minutes, has four basal programs, is waterproof, has single-button bolus delivery, and has a backlight for easy viewing in the dark. One interesting feature is the assortment of pump covers that help pump wearers adapt the pump to what they're wearing. You can see how to operate the pump at the Animas web site.

  3. Therasense showed their new Freestyle meter:

    Freestyle Sample
      Therasense showed their new Freestyle meter to excited crowds. Using just 0.3 microliters, the Freestyle requires one-fifth of the blood of the next best meter -- the FastTake using its new test strips. Because it uses so little blood, the Freestyle can be used for "alternative site testing," which means places other than the finger tips. Everyone who tried the Freestyle on their arm reporting feeling nothing. For more information, see the Therasense website.

  4. LifeScan announced a new test strip for the FastTake:

    Product   LifeScan announced a new test strip for its FastTake meter, now called the OneTouch FastTake. The new strip takes only 1.5 microliters and has FDA approval for "alternative site testing," just like the Freestyle. The new strip is end fill, rather than top fill like the old FastTake strips. For more information, see the LifeScan FastTake website. You can read their press release, which has a video news release. (Bring a fast connection -- it's 6.2 MB.)

Research and Poster Presentations

Abstracts from the 60th Scientific Sessions of the American Diabetes Association are online for you to review. Here are some selected abstracts:

  1. A study by members of the Children's Hospital of Pittsburgh reports that 94% of families are satisfied with the care their children receive at school. This is significantly higher than our recent poll suggests.

  2. Study finds insulin pumps to be an effective alternative to insulin injection therapy in children and adolescents.

  3. Study shows that a small dose of glucagon is a safe and effective means of managing children and adolescents with impending hypoglycemia.

  4. Study explores the relationship of energy balance to additional food for nocturnal hypoglycemia in children with type 1 diabetes during summer camps.

  5. Study shows that parental knowledge of diabetes care directly correlates with children's HbA1c values.

  6. Study reviews Management of Hypoglycemia by Children with Diabetes and Their Parents.

  7. Detailed Data from a Continuous Glucose Monitoring System (CGMS) Facilitates Comprehensive Diabetes Management Recommendations.

  8. Study explores the Psychological Impact of Screening Programs in Mothers of Children At-Risk for Type 1 Diabetes.

  9. Study shows that children with recently diagnosed diabetes report similar quality of life satisfaction as kids without diabetes.

  10. Study found that Severe Hypoglycemia Does Not Impair Cognitive Function in Older Children with Diabetes Over a 9-Month Interval.

  11. Study explored the impact of insurance on the care for people with Type 1 diabetes.

Posted June 4, 2000
Updated June 18, 2000

  Home Return to Top

Last Updated: Thursday August 29, 2002 21:04:40
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.